-- 
Bouygues, Havas, NRJ, Vivalis: French Equity Preview

-- B y   F r a n k   C o n n e l l y
-- 
2011-08-31T12:04:29Z

-- http://www.bloomberg.com/news/2011-08-30/bouygues-havas-nrj-vinci-vivalis-french-equity-preview.html
(Corrects to show Vivalis had a loss in the first half
last year.)  The following companies’ shares may
be active in Paris. Symbols are in parentheses after company
names and prices are from the last close.  France ’s CAC 40 Index rose 5.54 points, or 0.2 percent, to
3,159.74. The  SBF 120 Index (SBF120)  advanced 0.3 percent.  Bouygues SA (EN)  : The French building, television and
telecommunications company delayed publication of its second-
quarter earnings until 7:00 a.m. in Paris, citing a “financial
transaction.” The shares rose 1.5 percent to 23.09 euros.  Colas SA (RE)  : The construction company reported a
first-half net income of 2 million euros, compared with a year-
earlier loss of 29 million euros. The stock fell 0.1 percent to
126.69 euros.  Financiere de l’Odet (ODET)  : The holding company said
first-half net income doubled to 222 million euros. The stock
declined 0.5 percent to 312 euros.  Haulotte Group (PIG FP): The maker of lifting platforms for
building sites said its first-half net loss narrowed to 14.7
million euros from a loss of 16 million euros. The shares rose
3.3 percent to 10.21 euros.  Havas SA (HAV)  : The owner of the Euro RSCG advertising
agency had first-half net income of 53 million euros, compared
with 49 million euros a year earlier. The shares fell 0.2
percent to 2.75 euros.  Lanson-BCC (LAN)  : The champagne maker said first-half
revenue advanced to 109 million euros from 104.3 million euros.
The shares added 3.1 percent to 50 euros.  NRJ Group (NRG)  : The French radio station group said
first-half net income gained to 16.1 million euros from 9.9
million euros. The stock rose 2 percent to 7.14 euros.  Vinci SA (DG)  : The French construction company said
first-half net income rose 16 percent to 814 million euros. The
stock advanced 0.4 percent to 35.54 euros.  Vivalis SA (VLS)  : The stem-cell research concern
reported a first-half loss of 3.07 million euros, compared with
a loss of 5.92 million euros a year earlier. The stock slid 0.6
percent to 6.66 euros.  To contact the reporter on this story:
Frank Connelly in Paris at 
 fconnelly@bloomberg.net   To contact the editor responsible for this story:
Andrew Rummer at 
 arummer@bloomberg.net  